G-Therapeutics
Develop novel neuro-stimulation therapy for spinal cord injury
G-Therapeutics has raised €36M across 2 funding rounds from 5 investors, most recently a Debt round in Apr 2016. Based in Eindhoven, Netherlands; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€36M
€36,000,000
Funding rounds
2
Investors
5
distinct backers
Active since
2016-04
latest 2016-04
Funding by year
EUR raised per yearG-Therapeutics — funding by year — interactive chart.
Data table
| G-Therapeutics — funding by year | |
|---|---|
| 2016 | €36M |
Signals
High confidenceRaise-next likelihood10
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-04-01 | Debt | €10M | RVO.nl | View deal → |
| 2016-04-01 | Series A | €26M | GIMV,INKEF Capital,LSP,Wellington Partners | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData